To explore the heterogeneous responsiveness to FNC across the three HCC cell lines and its association with HEY1, we overexpressed C-terminal Myc-tagged HEY1 in HepG2 and PLC/PRF/5 cells prior to FNC treatment. The gene discussed is MYC; the disease is hepatocellular carcinoma.